Review




Structured Review

Abmart Inc cebpd antibody
Diagnostic Performance and Clinical Relevance of <t>CEBPD</t> <t>and</t> <t>GPD1</t> in MASH Patients. ( A ) Comparison of risk distributions between patients with MASH and healthy controls in the test set. ( B ) ROC curves assessed the model’s diagnostic performance in the test set. ROC curves assessed the diagnostic performance of CEBPD ( C ) and GPD1 ( D ) in the train set. ( E ) Comparison of CEBPD and GPD1 expression levels between patients with MASH and HC in the test set. ROC curves evaluated the diagnostic performance of CEBPD ( F ) and GPD1 ( G ) in the test set. ( H and I ) The association between the expression level of CEBPD and GPD1 and the fibrosis stage. * p < 0.05, *** p < 0.001, **** p < 0.0001, ns not significant ( p ≥ 0.05).
Cebpd Antibody, supplied by Abmart Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cebpd+antibody/pmc12571002-81-9-14?v=Abmart+Inc
Average 86 stars, based on 1 article reviews
cebpd antibody - by Bioz Stars, 2026-07
86/100 stars

Images

1) Product Images from "Identification and Validation of Lipid Metabolism-Related Biomarkers GPD1 and CEBPD in Metabolic Dysfunction-Associated Steatohepatitis"

Article Title: Identification and Validation of Lipid Metabolism-Related Biomarkers GPD1 and CEBPD in Metabolic Dysfunction-Associated Steatohepatitis

Journal: Journal of Inflammation Research

doi: 10.2147/JIR.S524204

Diagnostic Performance and Clinical Relevance of CEBPD and GPD1 in MASH Patients. ( A ) Comparison of risk distributions between patients with MASH and healthy controls in the test set. ( B ) ROC curves assessed the model’s diagnostic performance in the test set. ROC curves assessed the diagnostic performance of CEBPD ( C ) and GPD1 ( D ) in the train set. ( E ) Comparison of CEBPD and GPD1 expression levels between patients with MASH and HC in the test set. ROC curves evaluated the diagnostic performance of CEBPD ( F ) and GPD1 ( G ) in the test set. ( H and I ) The association between the expression level of CEBPD and GPD1 and the fibrosis stage. * p < 0.05, *** p < 0.001, **** p < 0.0001, ns not significant ( p ≥ 0.05).
Figure Legend Snippet: Diagnostic Performance and Clinical Relevance of CEBPD and GPD1 in MASH Patients. ( A ) Comparison of risk distributions between patients with MASH and healthy controls in the test set. ( B ) ROC curves assessed the model’s diagnostic performance in the test set. ROC curves assessed the diagnostic performance of CEBPD ( C ) and GPD1 ( D ) in the train set. ( E ) Comparison of CEBPD and GPD1 expression levels between patients with MASH and HC in the test set. ROC curves evaluated the diagnostic performance of CEBPD ( F ) and GPD1 ( G ) in the test set. ( H and I ) The association between the expression level of CEBPD and GPD1 and the fibrosis stage. * p < 0.05, *** p < 0.001, **** p < 0.0001, ns not significant ( p ≥ 0.05).

Techniques Used: Diagnostic Assay, Comparison, Expressing

Immune Cell Profiling and Correlation with CEBPD and GPD1 Expression in MASH. ( A ) Heatmap showing correlations between 28 immune cell types in MerCorhort. ( B ) Heatmap showing the infiltrating enrichment of 28 immune cell types in MerCorhort. ( C ) Boxplot depicting differences in immune cell infiltration between patients with MASH and healthy controls. ( D ) Heatmap showing the correlation between CEBPD and GPD1 expression and immune cells in MASH. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, ns not significant ( p ≥ 0.05).
Figure Legend Snippet: Immune Cell Profiling and Correlation with CEBPD and GPD1 Expression in MASH. ( A ) Heatmap showing correlations between 28 immune cell types in MerCorhort. ( B ) Heatmap showing the infiltrating enrichment of 28 immune cell types in MerCorhort. ( C ) Boxplot depicting differences in immune cell infiltration between patients with MASH and healthy controls. ( D ) Heatmap showing the correlation between CEBPD and GPD1 expression and immune cells in MASH. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, ns not significant ( p ≥ 0.05).

Techniques Used: Expressing

Validation of GPD1 and CEBPD in a MASH Animal Model. ( A ) IHC staining of normal and MASH liver tissues, n = 6, 400×, scale bar 100 μm. ( B ) AOD values for GPD1 in CON and MASH groups. ( C ) AOD values for CEBPD in CON and MASH groups. ( D ) WB analysis of normal and MASH liver tissues, n = 3. ( E ) Relative gray value measurements for GPD1 in CON and MASH groups. ( F ) Relative gray value measurements for CEBPD in CON and MASH groups. *** p ≤ 0.001.**** p ≤ 0.0001.
Figure Legend Snippet: Validation of GPD1 and CEBPD in a MASH Animal Model. ( A ) IHC staining of normal and MASH liver tissues, n = 6, 400×, scale bar 100 μm. ( B ) AOD values for GPD1 in CON and MASH groups. ( C ) AOD values for CEBPD in CON and MASH groups. ( D ) WB analysis of normal and MASH liver tissues, n = 3. ( E ) Relative gray value measurements for GPD1 in CON and MASH groups. ( F ) Relative gray value measurements for CEBPD in CON and MASH groups. *** p ≤ 0.001.**** p ≤ 0.0001.

Techniques Used: Biomarker Discovery, Animal Model, Immunohistochemistry



Similar Products

86
Abmart Inc cebpd antibody
Diagnostic Performance and Clinical Relevance of <t>CEBPD</t> <t>and</t> <t>GPD1</t> in MASH Patients. ( A ) Comparison of risk distributions between patients with MASH and healthy controls in the test set. ( B ) ROC curves assessed the model’s diagnostic performance in the test set. ROC curves assessed the diagnostic performance of CEBPD ( C ) and GPD1 ( D ) in the train set. ( E ) Comparison of CEBPD and GPD1 expression levels between patients with MASH and HC in the test set. ROC curves evaluated the diagnostic performance of CEBPD ( F ) and GPD1 ( G ) in the test set. ( H and I ) The association between the expression level of CEBPD and GPD1 and the fibrosis stage. * p < 0.05, *** p < 0.001, **** p < 0.0001, ns not significant ( p ≥ 0.05).
Cebpd Antibody, supplied by Abmart Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cebpd+antibody/pmc12571002-81-9-14?v=Abmart+Inc
Average 86 stars, based on 1 article reviews
cebpd antibody - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology anti cebpd
Diagnostic Performance and Clinical Relevance of <t>CEBPD</t> <t>and</t> <t>GPD1</t> in MASH Patients. ( A ) Comparison of risk distributions between patients with MASH and healthy controls in the test set. ( B ) ROC curves assessed the model’s diagnostic performance in the test set. ROC curves assessed the diagnostic performance of CEBPD ( C ) and GPD1 ( D ) in the train set. ( E ) Comparison of CEBPD and GPD1 expression levels between patients with MASH and HC in the test set. ROC curves evaluated the diagnostic performance of CEBPD ( F ) and GPD1 ( G ) in the test set. ( H and I ) The association between the expression level of CEBPD and GPD1 and the fibrosis stage. * p < 0.05, *** p < 0.001, **** p < 0.0001, ns not significant ( p ≥ 0.05).
Anti Cebpd, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cebpd+antibody/pm40037690-356-13-15?v=Santa+Cruz+Biotechnology
Average 93 stars, based on 1 article reviews
anti cebpd - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

90
Absolute Biotech Inc anti-c/ebp delta (cebpd) rabbit polyclonal antibody
Diagnostic Performance and Clinical Relevance of <t>CEBPD</t> <t>and</t> <t>GPD1</t> in MASH Patients. ( A ) Comparison of risk distributions between patients with MASH and healthy controls in the test set. ( B ) ROC curves assessed the model’s diagnostic performance in the test set. ROC curves assessed the diagnostic performance of CEBPD ( C ) and GPD1 ( D ) in the train set. ( E ) Comparison of CEBPD and GPD1 expression levels between patients with MASH and HC in the test set. ROC curves evaluated the diagnostic performance of CEBPD ( F ) and GPD1 ( G ) in the test set. ( H and I ) The association between the expression level of CEBPD and GPD1 and the fibrosis stage. * p < 0.05, *** p < 0.001, **** p < 0.0001, ns not significant ( p ≥ 0.05).
Anti C/Ebp Delta (Cebpd) Rabbit Polyclonal Antibody, supplied by Absolute Biotech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cebpd+antibody/pm39756106-65-52-62?v=Absolute+Biotech+Inc
Average 90 stars, based on 1 article reviews
anti-c/ebp delta (cebpd) rabbit polyclonal antibody - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology cebpd antibodies
Diagnostic Performance and Clinical Relevance of <t>CEBPD</t> <t>and</t> <t>GPD1</t> in MASH Patients. ( A ) Comparison of risk distributions between patients with MASH and healthy controls in the test set. ( B ) ROC curves assessed the model’s diagnostic performance in the test set. ROC curves assessed the diagnostic performance of CEBPD ( C ) and GPD1 ( D ) in the train set. ( E ) Comparison of CEBPD and GPD1 expression levels between patients with MASH and HC in the test set. ROC curves evaluated the diagnostic performance of CEBPD ( F ) and GPD1 ( G ) in the test set. ( H and I ) The association between the expression level of CEBPD and GPD1 and the fibrosis stage. * p < 0.05, *** p < 0.001, **** p < 0.0001, ns not significant ( p ≥ 0.05).
Cebpd Antibodies, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cebpd+antibody/pm38925326-316-13-15?v=Santa+Cruz+Biotechnology
Average 93 stars, based on 1 article reviews
cebpd antibodies - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology anti cebpd antibody c 6
Diagnostic Performance and Clinical Relevance of <t>CEBPD</t> <t>and</t> <t>GPD1</t> in MASH Patients. ( A ) Comparison of risk distributions between patients with MASH and healthy controls in the test set. ( B ) ROC curves assessed the model’s diagnostic performance in the test set. ROC curves assessed the diagnostic performance of CEBPD ( C ) and GPD1 ( D ) in the train set. ( E ) Comparison of CEBPD and GPD1 expression levels between patients with MASH and HC in the test set. ROC curves evaluated the diagnostic performance of CEBPD ( F ) and GPD1 ( G ) in the test set. ( H and I ) The association between the expression level of CEBPD and GPD1 and the fibrosis stage. * p < 0.05, *** p < 0.001, **** p < 0.0001, ns not significant ( p ≥ 0.05).
Anti Cebpd Antibody C 6, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cebpd+antibody/pm38925326-298-26-29?v=Santa+Cruz+Biotechnology
Average 93 stars, based on 1 article reviews
anti cebpd antibody c 6 - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology anti-human cebpd antibody clone c6
Diagnostic Performance and Clinical Relevance of <t>CEBPD</t> <t>and</t> <t>GPD1</t> in MASH Patients. ( A ) Comparison of risk distributions between patients with MASH and healthy controls in the test set. ( B ) ROC curves assessed the model’s diagnostic performance in the test set. ROC curves assessed the diagnostic performance of CEBPD ( C ) and GPD1 ( D ) in the train set. ( E ) Comparison of CEBPD and GPD1 expression levels between patients with MASH and HC in the test set. ROC curves evaluated the diagnostic performance of CEBPD ( F ) and GPD1 ( G ) in the test set. ( H and I ) The association between the expression level of CEBPD and GPD1 and the fibrosis stage. * p < 0.05, *** p < 0.001, **** p < 0.0001, ns not significant ( p ≥ 0.05).
Anti Human Cebpd Antibody Clone C6, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cebpd+antibody/pm39137729-262-16-21?v=Santa+Cruz+Biotechnology
Average 90 stars, based on 1 article reviews
anti-human cebpd antibody clone c6 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology anti cebpd antibody
Diagnostic Performance and Clinical Relevance of <t>CEBPD</t> <t>and</t> <t>GPD1</t> in MASH Patients. ( A ) Comparison of risk distributions between patients with MASH and healthy controls in the test set. ( B ) ROC curves assessed the model’s diagnostic performance in the test set. ROC curves assessed the diagnostic performance of CEBPD ( C ) and GPD1 ( D ) in the train set. ( E ) Comparison of CEBPD and GPD1 expression levels between patients with MASH and HC in the test set. ROC curves evaluated the diagnostic performance of CEBPD ( F ) and GPD1 ( G ) in the test set. ( H and I ) The association between the expression level of CEBPD and GPD1 and the fibrosis stage. * p < 0.05, *** p < 0.001, **** p < 0.0001, ns not significant ( p ≥ 0.05).
Anti Cebpd Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cebpd+antibody/pm39137729-435-7-9?v=Santa+Cruz+Biotechnology
Average 96 stars, based on 1 article reviews
anti cebpd antibody - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology antibodies targeting cebpd
A <t>Cebpd</t> expression in U-IRI mice. Tubular epithelial cells were recognized with <t>E-cadherin</t> <t>antibodies</t> (green); CEBPD was recognized with specific CEBPD antibodies (red). The dead epithelial cells are marked with yellow arrows. Images were taken with a fluorescence microscope at a magnification of 200×. ( n = 3 for each group). B Cebpd is mainly induced in the kidney epithelial cells of U-IRI mice following the quantification of fluorescence intensity using ImageJ software (Student’s t test; * P < 0.05, ** P < 0.01, *** P < 0.001).
Antibodies Targeting Cebpd, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cebpd+antibody/pmc11258324-208-7-11?v=Santa+Cruz+Biotechnology
Average 93 stars, based on 1 article reviews
antibodies targeting cebpd - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

Image Search Results


Diagnostic Performance and Clinical Relevance of CEBPD and GPD1 in MASH Patients. ( A ) Comparison of risk distributions between patients with MASH and healthy controls in the test set. ( B ) ROC curves assessed the model’s diagnostic performance in the test set. ROC curves assessed the diagnostic performance of CEBPD ( C ) and GPD1 ( D ) in the train set. ( E ) Comparison of CEBPD and GPD1 expression levels between patients with MASH and HC in the test set. ROC curves evaluated the diagnostic performance of CEBPD ( F ) and GPD1 ( G ) in the test set. ( H and I ) The association between the expression level of CEBPD and GPD1 and the fibrosis stage. * p < 0.05, *** p < 0.001, **** p < 0.0001, ns not significant ( p ≥ 0.05).

Journal: Journal of Inflammation Research

Article Title: Identification and Validation of Lipid Metabolism-Related Biomarkers GPD1 and CEBPD in Metabolic Dysfunction-Associated Steatohepatitis

doi: 10.2147/JIR.S524204

Figure Lengend Snippet: Diagnostic Performance and Clinical Relevance of CEBPD and GPD1 in MASH Patients. ( A ) Comparison of risk distributions between patients with MASH and healthy controls in the test set. ( B ) ROC curves assessed the model’s diagnostic performance in the test set. ROC curves assessed the diagnostic performance of CEBPD ( C ) and GPD1 ( D ) in the train set. ( E ) Comparison of CEBPD and GPD1 expression levels between patients with MASH and HC in the test set. ROC curves evaluated the diagnostic performance of CEBPD ( F ) and GPD1 ( G ) in the test set. ( H and I ) The association between the expression level of CEBPD and GPD1 and the fibrosis stage. * p < 0.05, *** p < 0.001, **** p < 0.0001, ns not significant ( p ≥ 0.05).

Article Snippet: The GPD1 antibody was obtained from Proteintech, while the CEBPD antibody was sourced from Abmart.

Techniques: Diagnostic Assay, Comparison, Expressing

Immune Cell Profiling and Correlation with CEBPD and GPD1 Expression in MASH. ( A ) Heatmap showing correlations between 28 immune cell types in MerCorhort. ( B ) Heatmap showing the infiltrating enrichment of 28 immune cell types in MerCorhort. ( C ) Boxplot depicting differences in immune cell infiltration between patients with MASH and healthy controls. ( D ) Heatmap showing the correlation between CEBPD and GPD1 expression and immune cells in MASH. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, ns not significant ( p ≥ 0.05).

Journal: Journal of Inflammation Research

Article Title: Identification and Validation of Lipid Metabolism-Related Biomarkers GPD1 and CEBPD in Metabolic Dysfunction-Associated Steatohepatitis

doi: 10.2147/JIR.S524204

Figure Lengend Snippet: Immune Cell Profiling and Correlation with CEBPD and GPD1 Expression in MASH. ( A ) Heatmap showing correlations between 28 immune cell types in MerCorhort. ( B ) Heatmap showing the infiltrating enrichment of 28 immune cell types in MerCorhort. ( C ) Boxplot depicting differences in immune cell infiltration between patients with MASH and healthy controls. ( D ) Heatmap showing the correlation between CEBPD and GPD1 expression and immune cells in MASH. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, ns not significant ( p ≥ 0.05).

Article Snippet: The GPD1 antibody was obtained from Proteintech, while the CEBPD antibody was sourced from Abmart.

Techniques: Expressing

Validation of GPD1 and CEBPD in a MASH Animal Model. ( A ) IHC staining of normal and MASH liver tissues, n = 6, 400×, scale bar 100 μm. ( B ) AOD values for GPD1 in CON and MASH groups. ( C ) AOD values for CEBPD in CON and MASH groups. ( D ) WB analysis of normal and MASH liver tissues, n = 3. ( E ) Relative gray value measurements for GPD1 in CON and MASH groups. ( F ) Relative gray value measurements for CEBPD in CON and MASH groups. *** p ≤ 0.001.**** p ≤ 0.0001.

Journal: Journal of Inflammation Research

Article Title: Identification and Validation of Lipid Metabolism-Related Biomarkers GPD1 and CEBPD in Metabolic Dysfunction-Associated Steatohepatitis

doi: 10.2147/JIR.S524204

Figure Lengend Snippet: Validation of GPD1 and CEBPD in a MASH Animal Model. ( A ) IHC staining of normal and MASH liver tissues, n = 6, 400×, scale bar 100 μm. ( B ) AOD values for GPD1 in CON and MASH groups. ( C ) AOD values for CEBPD in CON and MASH groups. ( D ) WB analysis of normal and MASH liver tissues, n = 3. ( E ) Relative gray value measurements for GPD1 in CON and MASH groups. ( F ) Relative gray value measurements for CEBPD in CON and MASH groups. *** p ≤ 0.001.**** p ≤ 0.0001.

Article Snippet: The GPD1 antibody was obtained from Proteintech, while the CEBPD antibody was sourced from Abmart.

Techniques: Biomarker Discovery, Animal Model, Immunohistochemistry

A Cebpd expression in U-IRI mice. Tubular epithelial cells were recognized with E-cadherin antibodies (green); CEBPD was recognized with specific CEBPD antibodies (red). The dead epithelial cells are marked with yellow arrows. Images were taken with a fluorescence microscope at a magnification of 200×. ( n = 3 for each group). B Cebpd is mainly induced in the kidney epithelial cells of U-IRI mice following the quantification of fluorescence intensity using ImageJ software (Student’s t test; * P < 0.05, ** P < 0.01, *** P < 0.001).

Journal: Cell Death Discovery

Article Title: Epithelial CEBPD activates fibronectin and enhances macrophage adhesion in renal ischemia-reperfusion injury

doi: 10.1038/s41420-024-02082-4

Figure Lengend Snippet: A Cebpd expression in U-IRI mice. Tubular epithelial cells were recognized with E-cadherin antibodies (green); CEBPD was recognized with specific CEBPD antibodies (red). The dead epithelial cells are marked with yellow arrows. Images were taken with a fluorescence microscope at a magnification of 200×. ( n = 3 for each group). B Cebpd is mainly induced in the kidney epithelial cells of U-IRI mice following the quantification of fluorescence intensity using ImageJ software (Student’s t test; * P < 0.05, ** P < 0.01, *** P < 0.001).

Article Snippet: Subsequently, the slides were incubated with specific antibodies targeting CEBPD (sc‐365546; Santa Cruz Biotechnology), F4/80 (sc-377009; Santa Cruz Biotechnology), FN-1 (#15613-1-AP; Proteintech), and E-cadherin (GTX100443; GeneTex), each antibody was diluted at a ratio of 1:200.

Techniques: Expressing, Fluorescence, Microscopy, Software

A FN-1 levels are attenuated in the kidneys of Cebpd -deficient mice following U-IRI administration. FN-1 expression was examined via Western blotting and quantified by statistical analysis. (one-way ANOVA; * P < 0.05, ** P < 0.01, *** P < 0.001). B The number of macrophages surrounding epithelial cells was attenuated in the kidneys of U-IRI Cebpd -deficient mice. The macrophages were labeled with F4/80 (red) and FN-1 was detected using a specific anti-FN-1 antibody (green). The images were taken with a fluorescence microscope and magnified at 200×. C The fluorescence intensity of colocalized F4/80 and FN-1 signals in the kidneys of U-IRI mice was quantified by ImageJ software ( n = 6 for each group) (one-way ANOVA; * P < 0.05, ** P < 0.01, *** P < 0.001).

Journal: Cell Death Discovery

Article Title: Epithelial CEBPD activates fibronectin and enhances macrophage adhesion in renal ischemia-reperfusion injury

doi: 10.1038/s41420-024-02082-4

Figure Lengend Snippet: A FN-1 levels are attenuated in the kidneys of Cebpd -deficient mice following U-IRI administration. FN-1 expression was examined via Western blotting and quantified by statistical analysis. (one-way ANOVA; * P < 0.05, ** P < 0.01, *** P < 0.001). B The number of macrophages surrounding epithelial cells was attenuated in the kidneys of U-IRI Cebpd -deficient mice. The macrophages were labeled with F4/80 (red) and FN-1 was detected using a specific anti-FN-1 antibody (green). The images were taken with a fluorescence microscope and magnified at 200×. C The fluorescence intensity of colocalized F4/80 and FN-1 signals in the kidneys of U-IRI mice was quantified by ImageJ software ( n = 6 for each group) (one-way ANOVA; * P < 0.05, ** P < 0.01, *** P < 0.001).

Article Snippet: Subsequently, the slides were incubated with specific antibodies targeting CEBPD (sc‐365546; Santa Cruz Biotechnology), F4/80 (sc-377009; Santa Cruz Biotechnology), FN-1 (#15613-1-AP; Proteintech), and E-cadherin (GTX100443; GeneTex), each antibody was diluted at a ratio of 1:200.

Techniques: Expressing, Western Blot, Labeling, Fluorescence, Microscopy, Software

A Exogenous CEBPD activates FN-1 transcription in HK-2 cells. A RT‒qPCR assay was performed with total RNA from control and CEBPD-expressing vector transfectants. (Student’s t test; * P < 0.05, ** P < 0.01, *** P < 0.001). B Exogenous CEBPD activates the FN-1 reporter in HK-2 cells. A reporter assay was performed with cell lysates from the FN-1 reporter and control or CEBPD-expressing vector transfectants. (Student’s t test; * P < 0.05, ** P < 0.01, *** P < 0.001). C The inactivation of CEBPD attenuates hypoxia-induced FN-1 reporter activity in HK-2 cells. A reporter assay was performed with cell lysates from FN-1 reporter and lentiviral shcontrol (shCtl)- or shCEBPD (shCD)-infected transfectants. (one-way ANOVA; * P < 0.05, ** P < 0.01, *** P < 0.001). D CEBPD (CD) directly binds to the FN-1 gene promoter and this binding is responsive to hypoxia in HK-2 cells. A ChIP-PCR assay was performed with the indicated antibody-pull down formaldehyde-treated HK-2 cell lysates under normoxic (N) or hypoxic (H) conditions (Student’s t test; * P < 0.05, ** P < 0.01, *** P < 0.001).

Journal: Cell Death Discovery

Article Title: Epithelial CEBPD activates fibronectin and enhances macrophage adhesion in renal ischemia-reperfusion injury

doi: 10.1038/s41420-024-02082-4

Figure Lengend Snippet: A Exogenous CEBPD activates FN-1 transcription in HK-2 cells. A RT‒qPCR assay was performed with total RNA from control and CEBPD-expressing vector transfectants. (Student’s t test; * P < 0.05, ** P < 0.01, *** P < 0.001). B Exogenous CEBPD activates the FN-1 reporter in HK-2 cells. A reporter assay was performed with cell lysates from the FN-1 reporter and control or CEBPD-expressing vector transfectants. (Student’s t test; * P < 0.05, ** P < 0.01, *** P < 0.001). C The inactivation of CEBPD attenuates hypoxia-induced FN-1 reporter activity in HK-2 cells. A reporter assay was performed with cell lysates from FN-1 reporter and lentiviral shcontrol (shCtl)- or shCEBPD (shCD)-infected transfectants. (one-way ANOVA; * P < 0.05, ** P < 0.01, *** P < 0.001). D CEBPD (CD) directly binds to the FN-1 gene promoter and this binding is responsive to hypoxia in HK-2 cells. A ChIP-PCR assay was performed with the indicated antibody-pull down formaldehyde-treated HK-2 cell lysates under normoxic (N) or hypoxic (H) conditions (Student’s t test; * P < 0.05, ** P < 0.01, *** P < 0.001).

Article Snippet: Subsequently, the slides were incubated with specific antibodies targeting CEBPD (sc‐365546; Santa Cruz Biotechnology), F4/80 (sc-377009; Santa Cruz Biotechnology), FN-1 (#15613-1-AP; Proteintech), and E-cadherin (GTX100443; GeneTex), each antibody was diluted at a ratio of 1:200.

Techniques: Control, Expressing, Plasmid Preparation, Reporter Assay, Activity Assay, Infection, Binding Assay